Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study

Detalhes bibliográficos
Autor(a) principal: Paula, Anabela
Data de Publicação: 2019
Outros Autores: Carrilho, Eunice, Laranjo, Mafalda, Abrantes, Ana M., Casalta-Lopes, João, Botelho, Maria Filomena, Marto, Carlos Miguel, Ferreira, Manuel M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/107145
https://doi.org/10.3390/ma12203382
Resumo: (1) Background: Recently, tricalcium silicate cements, such as Biodentine™, have emerged. This biomaterial has a calcium hydroxide base and characteristics like mineral aggregate trioxide cements, but has tightening times that are substantially more suitable for their application and other clinical advantages. (2) Methods: A retrospective clinical study was conducted with 20 patients, which included a clinical evaluation of the presence or absence of pulp inflammation compatible symptoms, radiographic evaluation of the periapical tissues, and structural alterations of the coronary restoration that supports pulp capping therapies with Biodentine™ and WhiteProRoot®MTA. (3) Results: This clinical study revealed similar success rates between mineral trioxide cement and tricalcium silicates cements at 6 months, with 100% and 95% success rates, respectively. There were no statistically significant differences between both biomaterials and between these and the various clinical circumstances, namely the absolute isolation of the operating field, exposure size, the aetiology of exposure, and even the type of restorative material used. (4) Conclusions: Biodentine™ demonstrated a therapeutic effect on the formation of a dentin bridge accompanied by slight inflammatory signs, with a high clinical success rate, indicating the possibility of its effective and safe use in dental pulp direct capping in humans, similar to the gold standard material.
id RCAP_d0dd77ca95ac05a1b34ca83067a9ba70
oai_identifier_str oai:estudogeral.uc.pt:10316/107145
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Studybiocompatibilitybiomaterialsclinicaldirect pulp cappingpulp vitality(1) Background: Recently, tricalcium silicate cements, such as Biodentine™, have emerged. This biomaterial has a calcium hydroxide base and characteristics like mineral aggregate trioxide cements, but has tightening times that are substantially more suitable for their application and other clinical advantages. (2) Methods: A retrospective clinical study was conducted with 20 patients, which included a clinical evaluation of the presence or absence of pulp inflammation compatible symptoms, radiographic evaluation of the periapical tissues, and structural alterations of the coronary restoration that supports pulp capping therapies with Biodentine™ and WhiteProRoot®MTA. (3) Results: This clinical study revealed similar success rates between mineral trioxide cement and tricalcium silicates cements at 6 months, with 100% and 95% success rates, respectively. There were no statistically significant differences between both biomaterials and between these and the various clinical circumstances, namely the absolute isolation of the operating field, exposure size, the aetiology of exposure, and even the type of restorative material used. (4) Conclusions: Biodentine™ demonstrated a therapeutic effect on the formation of a dentin bridge accompanied by slight inflammatory signs, with a high clinical success rate, indicating the possibility of its effective and safe use in dental pulp direct capping in humans, similar to the gold standard material.MDPI2019-10-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/107145http://hdl.handle.net/10316/107145https://doi.org/10.3390/ma12203382eng1996-194431623190Paula, AnabelaCarrilho, EuniceLaranjo, MafaldaAbrantes, Ana M.Casalta-Lopes, JoãoBotelho, Maria FilomenaMarto, Carlos MiguelFerreira, Manuel M.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-06-12T08:26:54Zoai:estudogeral.uc.pt:10316/107145Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:23:30.516799Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study
title Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study
spellingShingle Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study
Paula, Anabela
biocompatibility
biomaterials
clinical
direct pulp capping
pulp vitality
title_short Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study
title_full Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study
title_fullStr Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study
title_full_unstemmed Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study
title_sort Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study
author Paula, Anabela
author_facet Paula, Anabela
Carrilho, Eunice
Laranjo, Mafalda
Abrantes, Ana M.
Casalta-Lopes, João
Botelho, Maria Filomena
Marto, Carlos Miguel
Ferreira, Manuel M.
author_role author
author2 Carrilho, Eunice
Laranjo, Mafalda
Abrantes, Ana M.
Casalta-Lopes, João
Botelho, Maria Filomena
Marto, Carlos Miguel
Ferreira, Manuel M.
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Paula, Anabela
Carrilho, Eunice
Laranjo, Mafalda
Abrantes, Ana M.
Casalta-Lopes, João
Botelho, Maria Filomena
Marto, Carlos Miguel
Ferreira, Manuel M.
dc.subject.por.fl_str_mv biocompatibility
biomaterials
clinical
direct pulp capping
pulp vitality
topic biocompatibility
biomaterials
clinical
direct pulp capping
pulp vitality
description (1) Background: Recently, tricalcium silicate cements, such as Biodentine™, have emerged. This biomaterial has a calcium hydroxide base and characteristics like mineral aggregate trioxide cements, but has tightening times that are substantially more suitable for their application and other clinical advantages. (2) Methods: A retrospective clinical study was conducted with 20 patients, which included a clinical evaluation of the presence or absence of pulp inflammation compatible symptoms, radiographic evaluation of the periapical tissues, and structural alterations of the coronary restoration that supports pulp capping therapies with Biodentine™ and WhiteProRoot®MTA. (3) Results: This clinical study revealed similar success rates between mineral trioxide cement and tricalcium silicates cements at 6 months, with 100% and 95% success rates, respectively. There were no statistically significant differences between both biomaterials and between these and the various clinical circumstances, namely the absolute isolation of the operating field, exposure size, the aetiology of exposure, and even the type of restorative material used. (4) Conclusions: Biodentine™ demonstrated a therapeutic effect on the formation of a dentin bridge accompanied by slight inflammatory signs, with a high clinical success rate, indicating the possibility of its effective and safe use in dental pulp direct capping in humans, similar to the gold standard material.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-16
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/107145
http://hdl.handle.net/10316/107145
https://doi.org/10.3390/ma12203382
url http://hdl.handle.net/10316/107145
https://doi.org/10.3390/ma12203382
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1996-1944
31623190
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134122163044352